Wayfinder Biosciences

About:

Wayfinder Biosciences develops RNA technologies for molecular detection and drug discovery.

Top Investors: IndieBio, SOSV, Conscience VC, Divergent Capital, Nicholas Chirls

Description:

Wayfinder Biosciences engineers RNA for molecular detection and drug discovery. The company employs proprietary computational design algorithms to engineer RNA switches that respond to specific chemicals and biomolecules. Wayfinder Biosciences was established in 2021 and is headquartered in San Francisco, CA and Seattle, WA.

Total Funding Amount:

$4.31M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)wayfinderbio.com

Founders:

Chuhern Hwang, David Sparkman-Yager, Jason Fontana

Number of Employees:

1-10

Last Funding Date:

2022-12-05

IPO Status:

Private

Industries: